[{"Assets_0_FY_USD":6245898000.0,"CommonStockSharesOutstanding_0_FY_shares":255172328.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":1270286000.0,"NetIncomeLoss_1_FY_USD":1550527000.0,"NetIncomeLoss_4_FY_USD":2096896000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":254868000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":254292000.0,"StockholdersEquity_0_FY_USD":4435203000.0,"EarningsPerShareBasic_1_FY_USD":6.08,"EarningsPerShareBasic_4_FY_USD":8.24,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190213"}]